baber/WOPTO huggingface dataset:
Patent CA-2789880-A1 (CA)
Title: Methods and mechanisms for transferring items
Inventor: OVERLEY MATTHEW BERNARD
IPC: B65B35/00
Filed: 2012-09-14
Abstract: A method of transferring items comprises feeding items toward a carrier mechanism from one or more input streams and engaging void areas in the items with one or more rods extending from the carrier mechanism. The method further comprises manipulating the carrier mechanism relative to the one or more input streams into a position substantially aligned with one or more output streams and feeding the items to the one or more output streams. The configuration of items in each input stream is different than the configuration of items in each output stream.
Patent CA-2792050-A1 (CA)
Inventor: DAVID OFER
IPC: G01S17/18
Filed: 2011-03-01
Abstract: System for detecting objects protruding from the surface of a body of water in a marine environment under low illumination conditions, the system comprising a gated light source, generating light pulses toward the body of water illuminating substantially an entire field of view, a gated camera, sensitive at least to wavelengths of the light generated by the gated light source, the gated camera receiving light reflected from at least one object, within the field of view, protruding from the surface of the body of water and acquiring a gated image of the reflected light, and a processor coupled with the gated light source and with the gated camera, the processor gating the gated camera to be set 'OFF' for at least the duration of time it takes the gated light source to produce a light pulse in its substantial entirety in addition to the time it takes the end of the light pulse to complete traversing a determined distance from the system and back to the gated camera, the processor further setting, for each pulse, the gated camera to be 'ON' for an 'ON' time duration until the light pulse, reflecting back from the object, is received by the gated camera.
Patent CA-2792807-A1 (CA)
Title: Improved dc bus regulator
Inventor: BOURGEAU EDWARD PETER KENNETH
IPC: H02J3/36
Filed: 2009-10-15
Abstract: An improved DC bus regulator that utilizes more transistor packs for power conversion at some times and diode, SCR, and resistor packs at other times.  The conversion technology is selected by the regulator based on the current load capacity and response required. For example, transistor packs may be used in low power load conditions. Through use of this hybrid system, the system obtains the desirable effects of transistor pack systems including fast response time, ability to regulate current, and bi--directional power conversion while mitigating the high costs and fragile nature of a system based solely on transistor packs.
Patent CA-2796157-A1 (CA)
Title: Scraper blade device for cleaning a surface and method
Inventor: VIGNEAULT JIMMY
IPC: E01H5/06
Filed: 2011-04-06
Abstract: The scraper blade device is provided for cleaning a surface, for instance a roadway surface, when moving in a forward direction relative to the surface. The scraper blade device includes an upper blade portion and a bottom blade portion. The bottom blade portion has a plurality of widthwise-disposed blade segments that are adjoined and juxtaposed to one another. The bottom edge of each blade segment is independently slidingly movable in an up and down movement out of alignment with reference to the bottom edge of the other blade segments and is biased towards a downward working direction. The bottom edge of the blade segments is also pivotally movable with reference to the surface to be cleaned about a pivot axis that is substantially parallel to the lowermost edge of the scraper blade device. The bottom edges is biased towards a forward working position.
Patent CA-2799036-A1 (CA)
Inventor: STILGENBAUER STEPHAN
IPC: C07K16/28
Filed: 2011-07-15
Abstract: The present invention describes CD37 antibodies, especially A2 and B2, for the treatment of patients with CLL, especially of patients belonging to a "high risk" or "ultra-high risk" group of patients. Those patients are either patients who are refractory to fludarabine treatment or patients who carry a genetic marker which is indicative for poor prognosis or increased risk of treatment failure, e.g. patients with TP53 dysfunction or deletion of chromosome 17p13, or patients after failure to previous anti-CD20 treatment. The ability of A2 and B2 to deplete CLL cells is high both in patient samples derived from patients with normal risk and with increased risk ("high risk" patients) and clearly superior to that of rituximab and alemtuzumab.
Patent CA-2800378-A1 (CA)
Inventor: BIRNBRICH PAUL
IPC: C08J9/28
Filed: 2011-02-18
Abstract: Nanoporous polymer foams can be obtained by reacting one or more epoxy resins with one or more amphiphilic epoxy resin hardeners in water in a phase inversion polymerization process, with the stipulation that the binder fraction of the polymer foams is within the range of 15 to 39.9 wt %. Said nanoporous polymer foams are suitable as heat-insulating materials.
Patent CA-2800464-A1 (CA)
Title: Gas turbine engine with low stage count low pressure turbine
Inventor: SUCIU GABRIEL L
IPC: F01D25/28
Filed: 2012-12-21
Abstract: A gas turbine engine includes a spool along an engine centerline axis which drives a gear train.
Patent CA-2802081-A1 (CA)
Inventor: HUBER-HAAG KARL-JOSEF
IPC: A23L33/00
Filed: 2011-05-27
Abstract: The present invention proposes a dispensing container (1) for probiotics (2) in a viscous or liquid carrier (3), the probiotics (2) having a higher specific weight than the viscous or liquid carrier (3), wherein the container (1) comprises a reservoir (4) for holding the carrier (3) and a dispensing head (5) being in fluid connection with the reservoir (4), the dispensing head (5) comprising at least one outlet (6), wherein the concentration of the probiotics (2) decreases from the outlet (6) of the dispensing head (5) towards a bottom portion (1a) of the reservoir (1).
Patent CA-2803399-A1 (CA)
Inventor: NAGAYAMA YUTAKA
IPC: F16B27/00
Filed: 2013-01-22
Abstract: There is provided to a chain of T-nuts in which the female screw is precisely worked. There is provided a chain of T-nuts including a plurality of T-nuts 1 connected with bridges 5 in a column, integrally formed from a strip of metal plate. Each of the T-nuts 1 includes a cylindrical shank 2 having openings at both ends, and an internal surface forming a female screw.  Each of the T-nuts includes flanges 5 provided at a periphery of one of the openings at a base side of the shank 2. Each of the T-nuts includes claws 4 provided at the flange 5 to be extended in a direction from the flange to a tip side of the shank 2. The claws 4 are formed by cutting and raised from an outside to an inside in a width direction of the strip of the metal plate.
Patent CA-2806549-A1 (CA)
Inventor: BACKHOLM ARI
IPC: H04W88/06
Filed: 2011-07-08
Abstract: Systems and methods of context aware traffic management for network and device resource conservation are disclosed. In one aspect, embodiments of the present disclosure include a method, which may be implemented on a system, for using characteristics of user activity on a mobile device to locally adjust behavior of the mobile device to optimize battery consumption on the mobile device.
Patent CA-2807849-A1 (CA)
Title: Foamed glass hydroponic substrate
Inventor: GRAY DON
IPC: C09K17/04
Filed: 2013-02-25
Abstract: A foamed glass plant growth support structure, including a foamed glass substrate and a plurality of interconnected pores distributed throughout the substrate.  The substrate is characterized by a porosity of at least about 65 percent. The pore size is substantially between about 0.2 and about 2 millimeters and the substrate is sufficiently chemically stable such that water filling the plurality of interconnected pores experiences a pH shift of less than 0.5.
Patent CA-2809990-A1 (CA)
Inventor: KREN STEFAN M
IPC: A61L27/38
Filed: 2011-09-01
Abstract: Described herein are methods of recellularizing, e.g., re-endothelializing, a decellularized organ or tissue matrix, which recellularized organ or tissue matrix may be introduced to a mammal. Recellularization may be accomplished by, for example, perfusion, using one or more conduits of the decellularized organ or tissue matrix such as decellularized vessels.
Patent CA-2811028-A1 (CA)
Title: Systems and methods for routing pressurized fluid
Inventor: KENDRICK WILLIAM DONALD
IPC: F04D13/12
Filed: 2011-09-09
Abstract: An apparatus for routing pressurized fluid from a fluid source is disclosed. The apparatus comprises a manifold assembly. The manifold assembly includes a frame, an intake section coupled to the frame, and an articulating arm coupled to the intake section. The intake section is configured to route pressurized fluid to the articulating arm. The articulating arm is configured to route pressurized fluid away from the intake section. The apparatus may further comprise a pre-assembled piping system. The pre-assembled piping system comprises an inlet for receiving fluid, said inlet being in fluid communication with the articulating arm of the manifold assembly, wherein the articulating arm is configured to direct fluid having a first pressure to a pump. The pre-assembled piping system also comprises a second articulating arm proximate to the articulating arm and configured to receive pressurized fluid from the pump, wherein the pressurized fluid has a second pressure greater than the first pressure; and a discharge line in fluid communication with the second articulating arm. A method of routing pressurized fluid from a fluid source is also disclosed.
Patent CA-2813510-A1 (CA)
Title: Curcuminoid solid dispersion formulation
Inventor: BREITENBACH JOERG
IPC: A23L5/20
Filed: 2011-10-13
Abstract: A curcuminoid formulation, comprising a melt-processed solid dispersion product comprising one or more curcuminoids, a nutritionally acceptable thermoplastic polymer, and a phosphatide; providing an improved oral bioavailability compared to non-formulated crystalline curcuminoid. A method for producing said formulation. A nutritional product fortified with said formulation. Said formulation for use in the treatment or prophylaxis of cancer, conditions involving an inflammatory reaction, neurological disorders, cardiovascular disease, pulmonary disease, the formation of cholesterol gallstones, and parasitic infestation.
Patent CA-2814288-A1 (CA)
Title: Systeme de ventilation et son procede de commande
Inventor: ZHANG ZHENG
IPC: F24F11/77
Filed: 2013-04-26
Abstract: Linvention propose un système de ventilation qui comprend un moteur à aimant permanent et une roue déolienne. Le moteur à aimant permanent comprend un ensemble stator, un ensemble rotor et un contrôleur de moteur. Lensemble rotor comprend un rotor à pôles saillants qui comprend un noyau de rotor et des aimants intégrés dans le noyau de rotor. Le contrôleur de moteur comprend un microprocesseur, un convertisseur de fréquence, et une unité de détecteur. Lunité de détecteur entre un courant de phase ou des courants de phase, une tension de phase et une tension de bus CC dans le microprocesseur. Le microprocesseur émet un signal pour contrôler le convertisseur de fréquence qui est connecté à un enroulement de lensemble stator. Le rapport entre un intervalle dair du moteur et lépaisseur des aimants varie de 0,03 à 0,065, et le rapport entre la longueur dun arc polaire et la longueur des aimants varie de 0,8 à 1,0.
Patent CA-2814374-A1 (CA)
Inventor: CROSBY ALFRED J
IPC: C09J7/30
Filed: 2011-10-21
Abstract: The invention provides novel devices, systems, designs, materials and fabrication methods that enable high-load capacity, easy release, and suitable for extended/repeated use in a variety of applications.
Patent CA-2814591-A1 (CA)
Inventor: HAIN RUEDIGER
IPC: A01H5/06
Filed: 2011-10-13
Abstract: The present invention relates to an ALS inhibitor herbicide tolerant Beta vulgaris plant and parts thereof comprising a mutation of an endogenous acetolactate synthase (ALS) gene, wherein the ALS gene encodes an ALS polypeptide containing an amino acid different from tryptophan at a position 569 of the ALS polypeptide.
Patent CA-2818254-A1 (CA)
Title: Personal eeg monitoring device with electrode validation
Inventor: KIDMOSE PREBEN
IPC: A61B5/374
Filed: 2011-01-20
Abstract: A personal wearable EEG monitor (1) is adapted to be carried at the head of a person. The EEG monitor comprises an EEG sensor part having skin surface electrodes (3) for measuring EEG signals from said person. The EEG monitor comprises an EEG signal analyzer (5, 5') adapted for having an EEG signal transferred from the EEG sensor part, and adapted for monitoring the EEG signal. The EEG monitor (1) further comprises EEG stimuli controlling means adapted for performing at least one of the following: providing a stimulus to the person, requesting the person to perform a stimuli creating act, or identifying a stimuli creating ambient sound. The EEG monitor comprises EEG response detection means for identifying an induced response from the EEG signal caused by the stimuli, and a classifier for deciding based on said induced response if the skin surface electrodes receive EEG signals.
Patent CA-2818298-A1 (CA)
Inventor: HONG HOTAEK
IPC: H04B7/04
Filed: 2011-04-28
Abstract: A broadcast signal receiver according to the present invention comprises: a demodulator for performing OFDM demodulation on a received broadcast signal including a frame for the delivery of a broadcast service; a frame demapper for outputting the frame, the frame including a preamble that contains first signaling information, and a plurality of link-layer-pipes (LLPs) that contain PLP data, second signaling information and third signaling information, with the PLP data including a base layer and an enhancement layer of the broadcast service; and a decoder for decoding the first signaling information, for decoding the second and third signaling information, and for selectively decoding the PLP data by using the third signaling information.
Patent CA-2818694-A1 (CA)
Inventor: BORKOWSKI SANDRA
IPC: A61P35/00
Filed: 2011-11-21
Abstract: The invention is directed to novel Lutetium-177-labeled bombesin analogs for treatment of tumor by radiotherapy.
Patent CA-2818921-A1 (CA)
Inventor: HELLSTROM HAROLD RICHARD
IPC: A61P29/00
Filed: 2006-07-21
Abstract: Methods and compositions for reducing the risks of adverse cardiovascular (CV) events associated with the administration of pharmaceutical agents which induce or increase the risk of one or more adverse CV events, particularly the non-steroidal anti-inflammatory drags (NSAIDs) and especially the cyclooxygenase-2 (COX-2) inhibitors, are disclosed. The methods involve the administration of compositions comprising the adverse CV  event-inducing agent and additional pharmaceutical agents for reducing the risk of adverse CV    events. In specific embodiments, the agent is selected from the group consisting of hydroxymethylglutaryl-coenzyme A reductase inhibitors (statins), angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs).
Patent CA-2822078-A1 (CA)
Inventor: SANDVIK LEIF
IPC: G16H20/13
Filed: 2011-11-15
Abstract: System for handling medical packages provided with at least one unique identifier (102) and other relevant information (103, 104). The system comprise at least one tracking device (106) arranged to accompany said package (101) all the way from the entry of the package (101) in the system to a possible decision on administration of the package-specific product content (105) to an intended recipient. The tracking device (106) comprises an integrated data logger that records data on at least one environmental parameter affecting remaining lifetime the product content (105), a calculation function that calculates a value for the remaining lifetime expectancy, and an integrated indicator device (107) showing an operator at least if the product content (105) has a remaining useful lifetime or not. The tracking device (106) has a unique device identity that can be read and in the system associated with said unique identity code (102) and the other relevant information (103, 104) so that all relevant data concerning the product content (105) can be handled and transferred between system devices without risk of confusion. The invention also concerns a medical package.
Patent CA-2822856-A1 (CA)
Inventor: LANDVIK SARA
IPC: C12N9/34
Filed: 2010-11-30
Abstract: The present invention relates to isolated polypeptides having glucoamylase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.
Patent CA-2824755-A1 (CA)
Inventor: LEE BAE KEUN
IPC: H04N7/26
Filed: 2012-09-06
Abstract: The present invention relates to a method for deriving a merge candidate block and a dev ice using same. An image decoding method involves decoding motion estimation region (MER) related information; determining whether or not a predicted target block and a spatial merge candidate block are included in the same MER; and determining the spatial merge candidate block to be an unavailable merge candidate block when the predicted target block and the spatial merge candidate block are included in the same MER. Accordingly, by parallely performing the method for inducing a merge candidate, parallel processing is enabled and the computation amount and implementation complexity are reduced.
Patent CA-2825715-A1 (CA)
Inventor: THIBAULT PAUL
IPC: B60R9/042
Filed: 2013-08-29
Abstract: The present document describes a ladder rack system for displacing a ladder between a loading/unloading position on one of a side, a front and a rear of a vehicle and a stored position on a roof top of a vehicle, the ladder having a first ladder end and a second ladder end, the ladder rack system comprising: a first assembly to be mounted on a first end of the roof top for receiving the first ladder end; and a second assembly to be mounted on a second end of the roof top at a distance from the first end for receiving the second ladder end, the second assembly comprising: a pivoting rail to be pivoted between the loading/unloading position in which the pivoting rail extends substantially vertically or at an angle on the one of a side, a front and a rear of the vehicle and the stored position in which the pivoting rail extends longitudinally along the roof top; and a carriage slidably mounted on the pivoting rail for receiving the second ladder end and for sliding along the pivoting rail when the pivoting rail is in the loading/unloading position; wherein when the carriage is slid on the roof of the vehicle, the pivoting rail can be pivoted in the stored position longitudinally along the roof top.
Patent CA-2828727-A1 (CA)
Inventor: NUNLEY MARK ALLEN
IPC: C07C5/333
Filed: 2012-02-29
Abstract: There is disclosed a method of coupling and integrating natural gas recovery and separation along with chemical conversion. In one embodiment, the method comprises extracting at least one natural gas component from a natural gas stream. Non-limiting examples of the component that can be extracted include ethane, propane, butanes, and pentanes. There is also disclosed a method that comprises contacting a natural gas stream with a catalyst under conditions that selectively convert the natural gas component into at least one product, such as ethylene, acetic acid, polyethylene, vinyl acetate, ethylene vinyl acetate, ethylene oxide, ethylene glycol, and their derivatives, propylene, polypropylene, propylene oxide, propylene glycol, acrylates, acrolein, acrylic acid, butenes, butadiene, methacrolein, methacrylic acid, methacrylates, and their derivatives. The products can then be separated from the remaining components of the natural gas stream. There is also disclosed a method of integrating the production of ethylene, acetic acid, and/or vinyl acetate with the polymerization of ethylene-based polymers, such as polyethylene, ethylene vinyl acetate, ethylene vinyl alcohol, polyvinyl acetate, and polyvinyl alcohol.
Patent CA-2829073-A1 (CA)
Title: Water soluble polymer powder formulation having improved dispersing properties
Inventor: BHARGAVA PRACHUR
IPC: C08B15/00
Filed: 2012-03-06
Abstract: The present invention relates generally to water soluble polymer powder formulations, and more particularly, to a cellulose ether formulation which in powder form is suitable for direct addition to water-based systems to produce smooth, lump free solutions. The cellulose ethers are crosslinked with an aldehyde crosslinker and include a dry weak acid which slows hydrolysis of the hermiacetal linkage formed by the crosslinker. The selected acid does not adversely affect solubility stability.
Patent CA-2831161-A1 (CA)
Title: Fusion protein for antagonizing angiogenesis inducible factors and uses thereof
Inventor: FANG JIANMIN
IPC: A61K38/17
Filed: 2012-05-18
Abstract: Disclosed are a fusion protein for inhibiting angiogenesis and uses thereof, and further disclosed are a fusion protein for VEGF receptor and FGF receptor and uses of the same in the treatment of diseases associated with regulation of angiogenesis.
Patent CA-2831475-A1 (CA)
Inventor: BAMFORD PASCAL
IPC: G06V10/58
Filed: 2012-05-04
Abstract: A method and system for spectral demultiplexing of fluorescent species, such as quantum dots, conjugated with a biological tissue. The process of demultiplexing involves a non- liner regression based on curve-fitting of estimated spectra of the quantum dots and confidence intervals describing the parameters of such fitting curve for typical quantum dots.
Patent CA-2832908-A1 (CA)
Title: Rare earth removal of hydrated and hydroxyl species
Inventor: CABLE ROBERT
IPC: C02F1/58
Filed: 2012-03-28
Abstract: This disclosure relates generally to methods and rare earth-containing additives removing target materials in the form of hydroxides, carbonates, hydrates, or oxyhydroxyls from, a typically aqueous, liquid medium.
Patent CA-2833898-A1 (CA)
Inventor: GONZALEZ DAVILA VICENTE
IPC: C23F11/00
Filed: 2012-04-03
Abstract: The invention relates to a stabilised compound eliminating and inhibiting scale in pipelines, containing a useful formulation for dissolving scale such as barium sulfate, calcium sulfate, calcium carbonate, magnesium carbonate, barium carbonate and ferric oxide. Said formulation consists of a group of organic and inorganic acids and is also stabilised by amines or alcohols of a high molecular weight, creating a highly-effective, low-corrosion fluid. The fluids that can be obtained by said invention ensure the least amount of damage to the pipelines used for the transport thereof and are compatible with various polymer materials. They progressively attack scale formed, solubilising said scale into an aqueous medium and decomposing the carbonate ion. The invention can be used in the petroleum industry as a scale inhibitor, an inorganic scale inhibitor, or a scale formation inhibitor (when applied in solution). When said compound is used to dissolve scale, it generates a gradual decomposition that enables fluid to enter over larger distances with an improved action, along the solid with which it comes into contact. The product interferes by means of an anion-cation interaction in potentially precipitating ions, inhibiting them and producing a set of agglomerates of low molecular weight and high stability, enabling them to remain in the solution wherein they are found without forming insoluble agglomerates.